Rifaximin overdosage: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Rifaximin}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTI...") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Overdosage== | |||
No specific information is available on the treatment of overdosage with XIFAXAN. In clinical studies at doses higher than the recommended dose (> 600 mg/day for travelers’ diarrhea or > 1100 mg/day for [[hepatic encephalopathy]]), adverse reactions were similar in subjects who received doses higher than the recommended dose and placebo. In the case of overdosage, discontinue XIFAXAN, treat symptomatically, and institute supportive measures as required.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | publisher = | date = | accessdate = }}</ref> | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1 | publisher = | date = | accessdate = }}</ref> | |||
Latest revision as of 21:36, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Overdosage
No specific information is available on the treatment of overdosage with XIFAXAN. In clinical studies at doses higher than the recommended dose (> 600 mg/day for travelers’ diarrhea or > 1100 mg/day for hepatic encephalopathy), adverse reactions were similar in subjects who received doses higher than the recommended dose and placebo. In the case of overdosage, discontinue XIFAXAN, treat symptomatically, and institute supportive measures as required.[1]
References
Adapted from the FDA Package Insert.